Home Cart Sign in  
Chemical Structure| 395683-14-4 Chemical Structure| 395683-14-4

Structure of Imrecoxib
CAS No.: 395683-14-4

Chemical Structure| 395683-14-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Imrecoxib is a selective COX-2 inhibitor.

Synonyms: BAP-909

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Imrecoxib

CAS No. :395683-14-4
Formula : C21H23NO3S
M.W : 369.48
SMILES Code : O=C1N(CCC)CC(C2=CC=C(S(=O)(C)=O)C=C2)=C1C3=CC=C(C)C=C3
Synonyms :
BAP-909
MDL No. :MFCD09832697

Safety of Imrecoxib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02456688 Knee Osteoarthritis PHASE1 UNKNOWN 2025-07-15 The frist affiliated hospital ... More >>of Fourth Military Medical University, Xi'an, Shanxi, 710032, China Less <<
NCT01985165 Knee Osteoarthritis PHASE4 UNKNOWN - The Second Affiliated Hospital... More >> of Sun Yat-Sen University, Guangzhou, Guangdong, China|Cangzhou Central Hospital, Cangzhou, Hebei, China|Tongji Hospital, Wuhan, Hubei, 430030, China|The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, 222002, China|Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China|Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China|Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China|Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong, 250014, China|The Second Hospital of Shangdong University, Jinan, Shandong, China|Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China|Taizhou Hospital, Taizhou, Zhejiang, China|BeijingChao-YangHospital, Beijing, 100020, China|China-Japan Friendship Hospital, Beijing, 100029, China|Peking University First Hospital, Beijing, 100034, China|Beijing Hospital of the Ministry of Health, Beijing, 100730, China|Peking Union Medical College Hospita, Beijing, China|Peking University Third Hospital, Beijing, China|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Chongqing, 400042, China|Tianjin First Center Hospital, Tianjin, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.71mL

0.54mL

0.27mL

13.53mL

2.71mL

1.35mL

27.07mL

5.41mL

2.71mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories